Literature DB >> 18562421

Is it time to revisit the role of psychedelic drugs in enhancing human creativity?

B Sessa1.   

Abstract

Human creativity is difficult to define and measure, but it is undoubtedly an important cognitive process. This makes it an interesting challenge for modern neuroscientific exploration - especially given the current interest in developing cognitive enhancers for commercial and clinical uses. There are similarities between the typical traits of creative people and the subjective psychological characteristics of the psychedelic (hallucinogenic) drug experience. This phenomenon was studied in a number of small trials and case studies in the 1960s. Results were inconclusive, and the quality of these studies - by modern research standards - was merely anecdotal. Nevertheless, with today's current renaissance in psychedelic drug research and the growing interest in cognitive enhancing drugs, now may be the time to re-visit these studies with contemporary research methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562421     DOI: 10.1177/0269881108091597

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  16 in total

Review 1.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

2.  Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.

Authors:  Rainer Kraehenmann; Dan Pokorny; Leonie Vollenweider; Katrin H Preller; Thomas Pokorny; Erich Seifritz; Franz X Vollenweider
Journal:  Psychopharmacology (Berl)       Date:  2017-04-07       Impact factor: 4.530

3.  Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.

Authors:  Evan J Kyzar; Christopher Collins; Siddharth Gaikwad; Jeremy Green; Andrew Roth; Louie Monnig; Mohamed El-Ounsi; Ari Davis; Andrew Freeman; Nicholas Capezio; Adam Michael Stewart; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-09       Impact factor: 5.067

4.  Psychedelic Microdosing: Prevalence and Subjective Effects.

Authors:  Lindsay P Cameron; Angela Nazarian; David E Olson
Journal:  J Psychoactive Drugs       Date:  2020-01-23

Review 5.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

6.  Restructuring consciousness -the psychedelic state in light of integrated information theory.

Authors:  Andrew R Gallimore
Journal:  Front Hum Neurosci       Date:  2015-06-12       Impact factor: 3.169

Review 7.  Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.

Authors:  Rainer Kraehenmann
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  Unifying Theories of Psychedelic Drug Effects.

Authors:  Link R Swanson
Journal:  Front Pharmacol       Date:  2018-03-02       Impact factor: 5.810

9.  The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity.

Authors:  Ido Hartogsohn
Journal:  Front Neurosci       Date:  2018-03-06       Impact factor: 4.677

Review 10.  Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.

Authors:  Jon G Dean
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.